Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shinbaro vs Celebrex in Knee Osteoarthritis
NCT01535417Phase 3Completed
- Sponsor
- GC Biopharma
- Start
- May 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of herbal medicine-Jaseng Medical Foundation in osteoarthritis (OA) (2 arms), sponsored by GC Biopharma. Primary endpoint: Change in Western Ontario and McMaster Universities Osteoarthritis Index at 12 weeks. Started May 2009; status: completed.
02
Drugs
herbal medicine-Jaseng Medical Foundation
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01535417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01535417.